Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease (Q24657714)

autosomal dominant polycystic kidney disease

Europe PubMed Central

title

Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease (English)

0 references

main subject

0 references

circulatory system

1 reference

cardiovascular abnormality

inferred from title

1 reference

Nature Reviews Nephrology

inferred from title

author

Robert William Schrier

series ordinal

2

object named as

Robert W Schrier

0 references

author name string

Tevfik Ecder

series ordinal

1

0 references

language of work or name

English

0 references

publication date

April 2009

0 references

published in

0 references

volume

5

0 references

issue

4

0 references

page(s)

221-8

0 references

cites work

Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Optimal care of autosomal dominant polycystic kidney disease patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Vascular expression of polycystin-2.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Causes of death in autosomal dominant polycystic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Pathogenesis of hypertension in autosomal dominant polycystic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Echocardiographic Findings in Autosomal Dominant Polycystic Kidney Disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Insulin resistance in adult polycystic kidney disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Abdominal aortic aneurysms and autosomal dominant polycystic kidney disease.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Hyperinsulinemia and left ventricular geometry in a work-site population in Japan.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Cardiovascular Abnormalities Associated with Adult Polycystic Kidney Disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Natriuretic response to volume expansion in polycystic kidney disease

30 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Vasopressin antagonists in polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

No effect of enalapril on progression in autosomal dominant polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Endothelial-derived vasoactive mediators in polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Vascular expression of polycystin.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Aneurysm of the splenic artery in a patient with autosomal dominant polycystic kidney disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Renal endothelin system in polycystic kidney disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Coronary aneurysms in patients with autosomal dominant polycystic kidney disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720315

Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality

28 November 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Autosomal dominant polycystic kidney disease in childhood: a longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Renal structure and hypertension in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

The anatomy of the renin-secreting cell in adult polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Role of vasopressin in essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Expansion of extracellular volume in early polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: possible evidence of heterogeneity in cystogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Plasma concentration of endothelin and arterial pressure in patients with ADPKD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Tissue Doppler Imaging in the Evaluation of Left Ventricular Function in Young Adults With Autosomal Dominant Polycystic Kidney Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

31 March 2020

12 December 2020

The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

No Effect of Angiotensin-Converting Enzyme Gene Polymorphism on Disease Progression and Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Intracranial aneurysms in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Intracranial aneurysms and dolichoectasia in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Progress in blood pressure control in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.13

Left ventricular hypertrophy in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

12 December 2020

Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension

1 reference

12 December 2020

The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10-year follow-up in a five-generation kindred

1 reference

12 December 2020

The spectrum of autosomal dominant polycystic kidney disease in children

1 reference

12 December 2020

Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2009.13

1 reference

Dimensions Publication ID

1017105395

0 references

1 reference

1 reference

PubMed publication ID

19322187

1 reference